Evidence map›Paper›PMID 30234106›Full record

ReviewFrontiers in bioengineering and biotechnology2018

Milica Nikolic, Tijana Sustersic, Nenad Filipovic

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Advancing Environmental ToxicologyEnvironment & health (Washington, D.C.) · 2024
    Review
  8. Review
  9. Review
  10. Progress and application of lung-on-a-chip for lung cancer.Frontiers in bioengineering and biotechnology · 2024
    Review
  11. Review
  12. Review
  13. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines.International journal of molecular sciences · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Biomimetic models of the glomerulus.Nature reviews. Nephrology · 2022
    Review
  18. Article
  19. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Milica NikolicFaculty of Engineering, University of Kragujevac, Kragujevac, Serbia.
Tijana SustersicFaculty of Engineering, University of Kragujevac, Kragujevac, Serbia.
Nenad FilipovicFaculty of Engineering, University of Kragujevac, Kragujevac, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Calu-3epithelial barrierHepG2in vitro modelsorgan-on-a-chiptoxicology

Identifiers

PMID30234106
PMCPMC6129577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.